Two bottles of body wash sit side by side on a drugstore shelf. One has a small rabbit outline on the back panel. It costs about two dollars more.
Most people reach for the rabbit. The logo reads like a promise, and the promise sounds simple. No animal was hurt so this could exist.
This is what catches shoppers off guard. In the United States, “cruelty-free” carries no legal weight at all. The Food and Drug Administration says so on its own page about the phrase: “The unrestricted use of these phrases by cosmetic companies is possible because there are no legal definitions for these terms.”
That doesn’t mean every company printing those words is lying. Plenty are telling the truth. The problem is that the true thing they’re saying can be much narrower than the thing you heard.
The four kinds of label claim, and where this one sits
Almost every word on a package falls into one of four groups. Sorting them is most of the skill.
Some terms are defined in regulation. A federal rule spells out what the word requires, and a product that misses the mark is mislabeled. The USDA organic tiers work this way.
Some are governed by agency guidance. No rule defines the word, but an agency has published how it reads existing law when the word shows up in marketing. Environmental and green claims sit here, under the Federal Trade Commission’s Green Guides.
Some are certified by a private body. A nongovernmental organization writes a standard, checks companies against it and licenses a logo. The standard can be strict and the checking can be real. None of it is federal law.
And some are completely undefined. No rule, no guidance, no required certifier. Anyone may print the word on anything.
“Cruelty-free” and “not tested on animals” belong in that last group. There is no federal definition to violate, which is exactly why the phrases travel so freely. Private programs have stepped into the gap, and some of them are serious, but a company doesn’t need one to use the words.
What the FDA says, in its own words
The FDA’s page on the phrase has been around a long time. It first went up in March 1995, was updated in February 2000, and the agency lists its content as current as of February 2022. For a government page, it’s unusually direct.
The agency’s point is that shoppers read “cruelty-free” as a statement about everything that went into the product. Companies, though, may be making a statement about one slice of the process, at one moment in time.
The FDA doesn’t accuse anyone of fraud. It describes how the claim can be built, and the construction is the revelation.
Three ways a cruelty-free claim stays technically true
The FDA names three different foundations a company can stand on. Each one produces a sentence that holds up, and each one leaves a different hole.
The finished product only
A company can apply the claim to the finished product it sells and stop there. Any animal testing needed to support a safety conclusion can happen further up the chain, at a raw material supplier or a contract laboratory the company hires.
The sentence on the bottle is accurate. The bottle wasn’t tested on animals. The chain that produced what’s in the bottle is a separate question, and the label doesn’t address it.
Other kinds of evidence
A company can substantiate safety without animals at all. The FDA lists the routes: published scientific literature, non-animal test methods, safety testing on raw materials, and controlled studies in human volunteers.
This is the honest version of the claim, and it’s increasingly the normal one. It’s also invisible on a label. The same two words appear whether a company did this or did the first thing.
Materials tested decades ago
This is the one most shoppers have never considered, and it’s the one worth carrying out of this article.
Many of the raw materials used across the cosmetics industry were tested on animals years ago, when they were first introduced. That testing is done. The data exists. Nobody is repeating it.
A manufacturer can build a product entirely out of those legacy materials and say, truthfully, that its products are not currently tested on animals. The word doing the work is “currently.” The animal tests already happened. They happened before the company placed its order, sometimes decades before, and the ingredient is still on the shelf because of them.
That is not a trick in the legal sense. It is a true statement that most buyers would not recognize as the statement being made.
Picture a formulator choosing between two ingredients that do the same job. One has been in use since the 1970s and arrives with a thick file of old safety data. The other is new and would need fresh work before anyone could sign off on it. The old ingredient is cheaper, faster and leaves the claim on the bottle untouched. Nothing in that choice is dishonest. It also does nothing for any animal.
What US law requires
This guide covers the part that surprises people in the other direction. US law does not require animal testing for cosmetics, and never has.
The Federal Food, Drug, and Cosmetic Act requires cosmetics to be safe and properly labeled. According to the FDA, the Act doesn’t specifically require animal testing and doesn’t require the agency to approve a cosmetic before it goes on sale. The company is responsible for substantiating safety, and the FDA advises using testing that’s appropriate and effective.
The labeling rule is short. The FDA regulates cosmetic labels under that Act and the Fair Packaging and Labeling Act, and its standard is this: “Cosmetic labeling must be truthful and not misleading.” Truthful is the operative word, and a narrowly true statement clears the bar.
That framework got stronger in 2022. US cosmetics law had not seen a shift this big in generations, and it arrived in the Modernization of Cosmetics Regulation Act, shortened to MoCRA. Per the FDA, it requires the company responsible for a product to keep records supporting its safety, register manufacturing facilities and renew every two years, list each product and its ingredients and update that listing yearly, and report serious adverse events to the FDA within 15 business days along with a copy of the label. The FDA can order a recall if a company refuses a voluntary one.
What MoCRA does not do is dictate methods. The FDA states that neither the law nor its regulations require specific tests for a given product or ingredient, only that the data come from scientifically sound methods. And the agency’s page says plainly that animal testing is not required to market a cosmetic.
The warning label almost nobody has seen
There’s one more piece, and it’s an old one. A federal regulation at 21 CFR 740.10, on the books since March 1975, says a cosmetic whose safety hasn’t been adequately substantiated is misbranded unless the front of the package carries a warning that the product’s safety has not been determined.
Think about what that means in a store. If a company can’t back up its safety conclusion, the law’s answer isn’t a ban. It’s a sentence on the front panel. You’ve almost certainly never seen one, which tells you companies generally do substantiate safety one way or another. How they do it is the thing the cruelty-free claim is about.
If a product gives you a reaction
Labels aren’t a safety system. Your own skin is the one that reports back.
The FDA’s instruction is specific. Stop using the product and contact your health care provider. Then report it, whether or not you needed treatment. You can file a MedWatch report online, mail or fax Form FDA 3500B, or call the Food and Cosmetics Information Center at 1-888-SAFEFOOD and choose option 4.
The FDA wants to hear about rashes, redness, burns, hair loss, headache, infection or illness. It also takes reports of a bad smell, an odd color change, foreign material or contamination. A rash that starts within days of switching products, swelling around the eyes, or trouble breathing after using an aerosol or fragrance are not label questions. They’re clinician questions, and the breathing one is urgent.
The science that is replacing animal tests
The reason a modern company can skip animals is that the test methods got better.
The guiding idea is older than most people assume. According to a 2023 review in Food and Chemical Toxicology, the “3Rs” framework of replacement, reduction and refinement was introduced by Russell and Burch in 1959. Everything since has been an attempt to deliver on it.
The toolkit now includes in vitro methods, meaning tests run on cells and tissues in a dish; in chemico methods, which measure how a chemical reacts with proteins in a tube; and in silico methods, which are computer models that predict toxicity from a molecule’s structure. That same review notes that the cosmetics sector has led the adoption of these approaches, ahead of other industries.
The federal government has its own machinery for this work. The FDA says that in 1997 it joined 13 other federal agencies to form ICCVAM, an interagency committee that coordinates the development and validation of alternative test methods. The agency also says it follows the Animal Welfare Act and the Public Health Service policy on humane care of laboratory animals, and that when animal testing is used, it should come only after available alternatives have been considered, using the fewest animals and the most humane methods available.
A 2021 review in the Journal of Toxicology and Environmental Health, Part B, describes why the pace picked up. Since 2013, toxicity studies of cosmetic ingredients using animals have not been permitted in the European Union, which forced the development of alternatives across an industry that sells globally.
For skin, the replacements are mature. A 2025 paper in Regulatory Toxicology and Pharmacology walks through next-generation risk assessment for skin sensitization, which is the process where a substance teaches your immune system to react to it on later exposure. The authors used laboratory regression models to calculate a safe starting dose, then compared those numbers to values historically derived from human studies. The agreement supported the reliability of the non-animal models.
The honest limit
This is the trade-off, stated straight. The 2023 Food and Chemical Toxicology review says that for systemic toxicity, meaning effects on the whole body after a substance is absorbed, no standalone validated alternative model exists. Organ-on-chip systems and physiologically based models look promising and are not there yet.
So the picture is split. For skin irritation and sensitization, which is where most cosmetic risk lives, non-animal methods are established and in regulatory use. For whole-body effects, the science is still preliminary. A company sourcing a brand-new molecule faces a harder question than one using an ingredient with fifty years of history.
That is also why the legacy-material loophole exists. Old ingredients come with old data, and old data came from animals.
Private certifications and what a seal adds
Because the government defines nothing here, private programs do the defining. They are the only entities applying a written standard to the phrase.
The Leaping Bunny Program is the best known in the US. Its own site states that certified companies must eliminate animal testing at every stage of product development, covering ingredients, formulations and finished products, and that companies must stay open to independent third-party audits and recommit every year. The site says certification costs nothing, and the footer credits the American Anti-Vivisection Society.
Read that as what it is. A private organization’s standard, applied by that organization, renewed annually. Not a federal rule, not an FDA finding, and not interchangeable with the uncertified words “cruelty-free” printed by a company that answers to nobody.
What federal law does say about logos
There is a federal hook, just not where people expect. The Federal Trade Commission’s Endorsement Guides, at 16 CFR Part 255, treat an organization’s name or seal in advertising as an endorsement.
Two provisions matter here. Under section 255.4, an organization’s endorsement has to come from a process that fairly reflects the organization’s collective judgment, and if the ad presents the organization as an expert, it has to use recognized experts or standards it adopted beforehand that fit the product. Under section 255.5, a connection between the endorser and the seller that an audience wouldn’t expect, and that could affect how much weight the endorsement gets, must be disclosed clearly and conspicuously.
The practical translation: a logo a company invented for itself is a different object from a logo issued by an independent group that audits. Both can appear on a bottle. Only one of them is an outside judgment.
Seven questions to ask before you trust a bunny logo
This list is built for a shopper standing in an aisle with a phone, not for a compliance officer. Work down it and stop when you have your answer.
- Who issued the logo? If you can’t find an issuing organization, the company issued it to itself. That’s allowed, and it’s worth knowing.
- Does the standard cover ingredients and suppliers, or only the finished product? This single distinction separates the strongest claims from the weakest.
- Does anyone verify it, and who? Look for the words audit, third party or independent in the program’s own documents, not in the company’s marketing.
- Is the claim about this product or the whole company? A company can certify one line and leave the rest alone.
- How does the program handle ingredients tested long ago? This is the question almost nobody asks, and the answer tells you how seriously the standard was written.
- Is there a written policy, or only a picture? Serious programs publish criteria. If there’s a logo and no document behind it, you have a graphic.
- What is the logo not saying? A testing claim says nothing about whether the product works, what’s in it, how it was packaged, or how the people who made it were treated. Those are separate claims with separate rules, and green and sourcing claims in particular follow a completely different federal framework.
What to take away
If you remember one thing, make it the tense of the verb.
“Not currently tested on animals” is a statement about today. It says nothing about the history of the molecules in the bottle, and under FDA’s own description of the practice, a company can lean entirely on ingredients whose animal testing was finished decades ago.
So the useful move isn’t trusting or distrusting the phrase. It’s changing the question. Instead of asking whether a product is cruelty-free, ask who wrote the standard, what the standard covers, and who checks. Those three answers exist in writing for the serious programs and don’t exist at all for the rest.
And accept the limit honestly. A two-word claim on a back panel is a weak instrument for an ethical decision. It was never designed to carry one, and no federal definition is coming to make it stronger.
Sources
- U.S. Food and Drug Administration. “"Cruelty Free"/"Not Tested on Animals".” fda.gov
- U.S. Food and Drug Administration. “Animal Testing & Cosmetics.” fda.gov
- U.S. Food and Drug Administration. “Modernization of Cosmetics Regulation Act of 2022 (MoCRA).” fda.gov
- U.S. Food and Drug Administration. “How to Report a Cosmetic Product Related Complaint.” fda.gov
- U.S. Food and Drug Administration. “Cosmetics Labeling.” fda.gov
- Electronic Code of Federal Regulations (U.S. Government Publishing Office). “21 CFR 740.10 (labeling of cosmetics without adequate safety substantiation).” ecfr.gov
- Electronic Code of Federal Regulations (U.S. Government Publishing Office). “16 CFR Part 255 (FTC Endorsement Guides).” ecfr.gov
- Leaping Bunny Program. “Leaping Bunny (program home page).” leapingbunny.org
- PubMed. “Reddy N, Lynch B, Gujral J, Karnik K. "Alternatives to animal testing in toxicity testing: Current status and future perspectives in food safety assessments." Food and Chemical Toxicology, 2023. DOI: 10.1016/j.fct.2023.113944.” doi.org
- PubMed. “Kim KB, Kwack SJ, Lee JY, Kacew S, Lee BM. "Current opinion on risk assessment of cosmetics." Journal of Toxicology and Environmental Health, Part B, 2021. DOI: 10.1080/10937404.2021.1907264.” doi.org
- PubMed. “Lee I, Na M, Lavelle M, et al. "Quantitative next generation risk assessment for skin sensitization: application of regression models based on in vitro data to estimate point of departure." Regulatory Toxicology and Pharmacology, 2025. DOI: 10.1016/j.yrtph.2025.105964.” doi.org